Ardsley Advisory Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-7,000
| Closed | -$754K | – | 135 |
|
2020
Q1 | $754K | Sell |
7,000
-5,500
| -44% | -$592K | 0.3% | 44 |
|
2019
Q4 | $1.51M | Buy |
+12,500
| New | +$1.51M | 0.24% | 48 |
|
2019
Q3 | – | Sell |
-5,000
| Closed | -$546K | – | 136 |
|
2019
Q2 | $546K | Sell |
5,000
-3,000
| -38% | -$328K | 0.09% | 75 |
|
2019
Q1 | $894K | Sell |
8,000
-4,000
| -33% | -$447K | 0.17% | 49 |
|
2018
Q4 | $1.16M | Sell |
12,000
-500
| -4% | -$48.2K | 0.29% | 40 |
|
2018
Q3 | $1.52M | Buy |
12,500
+5,500
| +79% | +$671K | 0.21% | 49 |
|
2018
Q2 | $769K | Sell |
7,000
-6,500
| -48% | -$714K | 0.12% | 75 |
|
2018
Q1 | $1.44M | Sell |
13,500
-4,000
| -23% | -$427K | 0.22% | 56 |
|
2017
Q4 | $1.87M | Buy |
17,500
+4,000
| +30% | +$427K | 0.23% | 53 |
|
2017
Q3 | $1.5M | Sell |
13,500
-1,500
| -10% | -$167K | 0.2% | 60 |
|
2017
Q2 | $1.55M | Buy |
15,000
+3,000
| +25% | +$310K | 0.24% | 58 |
|
2017
Q1 | $1.17M | Hold |
12,000
| – | – | 0.18% | 59 |
|
2016
Q4 | $1.06M | Buy |
12,000
+3,000
| +33% | +$266K | 0.18% | 63 |
|
2016
Q3 | $868K | Buy |
9,000
+1,500
| +20% | +$145K | 0.14% | 67 |
|
2016
Q2 | $643K | Buy |
7,500
+1,500
| +25% | +$129K | 0.11% | 71 |
|
2016
Q1 | $522K | Buy |
+6,000
| New | +$522K | 0.08% | 66 |
|